Avari, Parizad https://orcid.org/0000-0001-9047-3589
Ranjani, Harish https://orcid.org/0000-0002-1521-7398
Nitika, Sharma https://orcid.org/0000-0001-9052-7719
Jagannathan, Narayanaswamy https://orcid.org/0000-0003-3804-5557
Mohan, Viswanathan https://orcid.org/0000-0001-5038-6210
Yadav, Ashutosh
Loomba, Menka
Tyagi, Akansha
Oliver, Nick https://orcid.org/0000-0003-3525-3633
Jha, Vinitaa
Chambers, John Campbell https://orcid.org/0000-0003-0209-4541
Valabhji, Jonathan https://orcid.org/0000-0001-9756-4061
Anjana, Ranjit Mohan https://orcid.org/0000-0002-4843-1374
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960, NIHR 16/136/68 & 132960)
Article History
Received: 4 January 2025
Accepted: 7 August 2025
First Online: 1 October 2025
Declarations
:
: This study has been given ethical approval for conduct in India by the Institutional Ethics Committee and registered with the Central Trials Registry of India (CTRI/2022/02/040650). Written informed consent to participate in the study will be obtained from all participants.
: JV was National Clinical Director for Diabetes and Obesity at NHS England from April 2013 to September 2023. During this time, he established and led the NHS Diabetes Prevention Programme, which has included digital interventions. NO has received honoraria for speaking and advisory board participation from Abbott Diabetes, Dexcom, Medtronic Diabetes, Tandem Diabetes, Sanofi, and Roche Diabetes and has received research funding from NIHR, Diabetes UK, Medtronic Diabetes and Dexcom. PA has received equipment from Dexcom for investigator-initiated studies. Other authors do not have any competing interests to declare.
: Not applicable.